Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$1.05 - $1.89 $14,490 - $26,082
-13,800 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$0.67 - $1.31 $20,711 - $40,494
-30,912 Reduced 69.14%
13,800 $15,000
Q2 2020

Aug 13, 2020

BUY
$0.67 - $1.31 $29,957 - $58,572
44,712 New
44,712 $42,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $172M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.